Spear Bio Launches SPEAR Ultradetec to Advance Neurodegenerative Disease Research
Toronto, July 30, 2025 Spear Bio, a pioneer in ultrasensitive immunoassay technology, has officially launched its next-generation product, SPEAR Ultradetect™, […]
Toronto, July 30, 2025 Spear Bio, a pioneer in ultrasensitive immunoassay technology, has officially launched its next-generation product, SPEAR Ultradetect™, […]
St. Louis, MO July 2025 MilliporeSigma, the U.S. life sciences division of Merck KGaA, Darmstadt, Germany, has entered into a
Orlando, FL July 2025 Plug and Play, the world-renowned global innovation platform, has announced the launch of its first-ever healthcare
July 2025 Gate Bioscience, a biotechnology innovator specializing in molecular gates a novel class of small-molecule drugs designed to remove
July 24, 2025 – The Office of the Assistant Secretary for Technology Policy (ASTP) has announced the release of United
Asia-Pacific is poised to become the fastest-growing region in the small-scale bioreactors market over the coming years, driven by several
North America continues to dominate the global neurostimulation devices market, holding a significant 60% share in 2024. Several key factors
AAVnerGene Inc., an innovative biotech company based in Rockville, MD, known for its cutting-edge AAV tissue-targeted delivery and manufacturing technologies,
Jiangsu Hengrui Pharmaceuticals Co., Ltd. and IDEAYA Biosciences, Inc. are set to showcase their groundbreaking research at the IASLC 2025
QIAGEN has launched its new QIAseq xHYB long-read panels, a cutting-edge solution designed to explore the complexities of genomically diverse